WTC
ALNY icon

WhitTier Trust Company’s Alnylam Pharmaceuticals ALNY Stock Holding History

WhitTier Trust Company’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.2K Sell
184
-35
-16% -$10.6K ﹤0.01% 708
2026
Q1 		$72.3K Buy
219
+137
+167% +$46.6K ﹤0.01% 654
2025
Q4 		$33.3K Sell
82
-33
-29% -$14.6K ﹤0.01% 792
2025
Q3 		$52.5K Buy
115
+63
+121% +$25.7K ﹤0.01% 682
2025
Q2 		$17K Buy
+52
New +$14.4K ﹤0.01% 1036

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WhitTier Trust Company's ALNY Position: Q2 2026 in Review

WhitTier Trust Company reduced its Alnylam Pharmaceuticals (ALNY) stake by 16% in Q2 2026, selling an estimated $10.6K and leaving 184 shares worth $59.2K. The position accounts for ﹤0.01% of the portfolio, ranked #708.

WhitTier Trust Company first reported a position in ALNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $72.3K in Q1 2026. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • WhitTier Trust Company held 184 shares of Alnylam Pharmaceuticals worth $59.2K as of Q2 2026.
  • WhitTier Trust Company sold 35 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $10.6K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #708 holding.
  • WhitTier Trust Company first reported a position in Alnylam Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • WhitTier Trust Company's Alnylam Pharmaceuticals position peaked at $72.3K in Q1 2026.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.